Nekkar ASA (OSL:NKR)
9.94
+0.04 (0.40%)
Aug 1, 2025, 4:25 PM CET
Revance Therapeutics Market Cap
Nekkar ASA has a market cap or net worth of 1.00 billion as of August 1, 2025. Its market cap has decreased by -19.39% in one year.
Market Cap
1.00B
Enterprise Value
848.21M
Revenue
583.51M
Ranking
n/a
PE Ratio
16.17
Stock Price
$9.94
Market Cap Chart
Since March 1, 2000, Nekkar ASA's market cap has increased from 133.63M to 1.00B, an increase of 649.98%. That is a compound annual growth rate of 8.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 998.17M | -3.92% |
Dec 30, 2024 | 1.04B | 5.90% |
Dec 29, 2023 | 981.07M | 50.63% |
Dec 30, 2022 | 651.32M | -38.65% |
Dec 30, 2021 | 1.06B | 65.87% |
Dec 30, 2020 | 640.05M | 195.62% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Kongsberg Gruppen ASA | 272.13B |
Aker ASA | 52.97B |
Tomra Systems ASA | 41.91B |
Wallenius Wilhelmsen ASA | 39.32B |
Hafnia | 27.81B |
DOF Group ASA | 23.41B |
Veidekke ASA | 22.31B |
BW LPG | 21.02B |